These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 20202514)

  • 1. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
    Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
    J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
    Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Hirose E; Kobayashi Y; Ohkawa K; Ohara M; Takafuji H; Sano F; Toyama Y; Kusachi S; Ohe T; Ito H
    Atherosclerosis; 2012 Jan; 220(1):134-8. PubMed ID: 22119063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
    Ishii H; Kobayashi M; Kurebayashi N; Yoshikawa D; Suzuki S; Ichimiya S; Kanashiro M; Sone T; Tsuboi H; Amano T; Uetani T; Harada K; Marui N; Murohara T
    Am J Cardiol; 2013 Aug; 112(3):363-8. PubMed ID: 23623047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
    Miyoshi T; Hirohata A; Usui S; Yamamoto K; Murakami T; Komatsubara I; Kusachi S; Ohe T; Nakamura K; Ito H
    Heart Vessels; 2014 Mar; 29(2):178-85. PubMed ID: 23563752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plaque burden with composition? That is the next question.
    Marso SP
    J Am Coll Cardiol; 2010 Mar; 55(10):983-5. PubMed ID: 20202515
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Puri R; Nissen SE; Menon V; Shao M; Hsu A; Bakris GL; Kastelein JJ; Williams B; Armbrecht J; Brunel P; Kataoka Y; Nicholls SJ
    Atherosclerosis; 2015 Dec; 243(2):553-9. PubMed ID: 26523993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
    Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K
    Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
    JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
    Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
    Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
    Berry C; L'Allier PL; Grégoire J; Lespérance J; Levesque S; Ibrahim R; Tardif JC
    Circulation; 2007 Apr; 115(14):1851-7. PubMed ID: 17389269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.
    Nicholls SJ; Hsu A; Wolski K; Hu B; Bayturan O; Lavoie A; Uno K; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2010 May; 55(21):2399-407. PubMed ID: 20488313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques.
    Kataoka Y; Wolski K; Balog C; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1035-41. PubMed ID: 24780871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of statins on serial coronary calcification during atheroma progression and regression.
    Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.
    Horikoshi T; Obata JE; Nakamura T; Fujioka D; Watanabe Y; Nakamura K; Watanabe K; Saito Y; Kugiyama K
    J Atheroscler Thromb; 2019 Dec; 26(12):1062-1074. PubMed ID: 30996201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
    Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
    Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
    Kataoka Y; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    J Am Coll Cardiol; 2012 May; 59(18):1592-7. PubMed ID: 22538329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
    Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
    Nicholls SJ; Bakris GL; Kastelein JJ; Menon V; Williams B; Armbrecht J; Brunel P; Nicolaides M; Hsu A; Hu B; Fang H; Puri R; Uno K; Kataoka Y; Bash D; Nissen SE
    JAMA; 2013 Sep; 310(11):1135-44. PubMed ID: 23999933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.